Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal. Coherus BioSciences shares jumped 22.1% to $2.98 in pre-market trading Here are some other stocks moving in pre-market trading. GainersNorthann Corp. (NYSE: NCL) shares jumped 19.9% to $1.63 in pre-market trading after jumping over 25% on Friday.HNR Acquisition Corp (NYSE: HNRA) gained 15.4% to $2.48 in pre-market trading.Porch Group, Inc. (NASDAQ: PRCH) gained 15.4% to $2…